StonvexLoading…
StonvexStonvexStonvexCore line items from PDYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.25M | $7.79M | $6.15M | $14.57M |
Operating Income | $-32.40M | $-26.92M | $-120.96M | $-177.04M |
Net Income | $10.04M | $-72.62M | $-115.59M | $-157.13M |
EPS (Diluted) | $0.24 | $-2.71 | $-4.51 | $-6.42 |
Total Assets | $95.71M | $56.25M | $60.43M | $167.63M |
Total Liabilities | $21.04M | $65.79M | $19.52M | $23.18M |
Cash & Equivalents | $18.22M | $31.19M | $23.14M | $35.16M |
Free Cash Flow OCF − CapEx | $-28.35M | $-22.89M | $-77.40M | $-66.89M |
Shares Outstanding | 46.12M | 33.88M | 25.88M | 25.71M |